TEE
ORGO icon

Tibra Equities Europe’s Organogenesis Holdings ORGO Stock Holding History

Tibra Equities Europe’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-46,366
Closed -$348K – 387
2019
Q1 		$348K Buy
+46,366
New +$926K 0.03% 313

Other funds holding ORGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Tibra Equities Europe's ORGO Position: Q2 2019 in Review

Tibra Equities Europe sold out of Organogenesis Holdings (ORGO) in Q2 2019, closing a stake of 46,366 shares — an estimated $348K sold.

Tibra Equities Europe first reported a position in ORGO in Q1 2019 and held it in 1 quarter. The position peaked at $348K in Q1 2019. 31 funds tracked by Wall St. Rank hold ORGO as of Q2 2019.

  • Tibra Equities Europe reported no remaining Organogenesis Holdings position as of Q2 2019 after selling out during the quarter.
  • Tibra Equities Europe sold 46,366 Organogenesis Holdings shares in Q2 2019, an estimated $348K.
  • Tibra Equities Europe first reported a position in Organogenesis Holdings in Q1 2019 and held it in 1 quarter.
  • Tibra Equities Europe's Organogenesis Holdings position peaked at $348K in Q1 2019.
  • 31 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2019.

Based on Tibra Equities Europe's 13F filing for Q2 2019, filed 1 Aug 2019.